The EPO published patent application EP3911384A1 filed by medmix Switzerland AG (inventor: Joachim Keitel) covering a dose delivery mechanism with spinning through prevention. The patent relates to medical device technology classified under A61M 5/315, addressing dosing precision issues in drug delivery systems. The patent is designated across European states including DE, FR, GB, IT, ES, NL, and others.\n\nHealthcare providers and manufacturers utilizing dose delivery devices should evaluate whether this patent affects existing products or development plans. No immediate compliance action is required; this is a publication notice of intellectual property rights rather than a regulatory requirement. Entities developing similar dose delivery mechanisms should review freedom-to-operate implications.